Anguraj Sadanandam: key facts
- Kind of voice
- Academic
- Role
- Professor in stratification and precision medicine at the ICR
- Quoted on
- Hospital discharge / bed-blocking
- Tracked press citations
- 1
- Most recently quoted
- 27 Aug 2026
“Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won't benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.”
Where Anguraj Sadanandam has been quoted
- AI to predict how bowel cancer patients will respond to new NHS drugtheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.